appScorecard
Performance
LowHasn't faired well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
Wanbury Ltd
WANBURY
Price Chart
Scorecard
Performance
LowHasn't faired well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
Key MetricsEdit
Forecast & RatingsDetailed Forecast
Price
Price Upside
—
Earnings
Earnings Growth
—
Revenue
Rev. Growth
—
Company Profile
Wanbury Limited is a pharmaceutical company which offers active pharmaceutical ingredient in over 70 countries.
PeersCompare with peers
Sun Pharmaceutical Industries Ltd
Cipla Ltd
Dr Reddy's Laboratories Ltd
Torrent Pharmaceuticals Ltd
Mankind Pharma Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Holdings TrendDetailed holdings
High Pledged Promoter HoldingLower pledged promoter holdings is considered better
A significant proportion of promoter holdings is pledged
Mutual Fund HoldingIncreasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock
In last 3 months, mutual fund holding of the company has almost stayed constant
Recent NewsAll news
Hmm, looks like data is unavailable here. Please come back after some timeRecent EventsAll events
Board Meeting Intimation
WANBURY LIMITED has informed the Exchange about Board Meeting to be held on 09-Jun-2023 to inter-alia consider and approve the Audited Financial results of the Company for the Yearly ended March 2023 . | Download
WANBURY LIMITED has informed the Exchange about Board Meeting to be held on 09-Jun-2023 to inter-alia consider and approve the Audited Financial results of the Company for the Yearly ended March 2023 . | Download
Board Meeting Intimation
WANBURY LIMITED has informed the Exchange about Board Meeting to be held on 30-May-2023 to inter-alia consider and approve the Audited Financial results of the Company for the Yearly ended March 2023 . | Download
WANBURY LIMITED has informed the Exchange about Board Meeting to be held on 30-May-2023 to inter-alia consider and approve the Audited Financial results of the Company for the Yearly ended March 2023 . | Download
Cash Dividend
Final • Div/Share: ₹ 1
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant